Novogene America is hosting the Novogene 10x Single-Cell Discovery Program on September 2, 2026, featuring sample processing, library preparation, sequencing, and bioinformatics analysis.

Public source

Publisher name

Public post

🚨 Tomorrow! Join Novogene for “Accelerate Your Cancer Research with the Novogene 10x Single-Cell Discovery Program.” Learn how the program can support innovative cancer…

Log in to read the full post

Company

Novogene America

Advancing Genomics, Improving Life

Industry
Biotechnology
Location
Sacramento, US
Company size
201–500 employees

About Novogene America

Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 45 NGS-related patents, as well as over 950 SCI articles with a total impact factor of more than 7970, including publications in first tiers journals such as Cell, Nature and Science. The UC Davis location of Novogene Corporation Inc. was opened in early 2016. We utilize Illumina platform to serve customers in North and South America, and we also offer PacBio and Nanopore services. Novogene Corporation Inc. is proud to have collaborated with scientists from the USA, Canada, Brazil, Colombia, Mexico, and so many more. We are excited to see this global collaboration and partnership growing.

See more

Latest activity

3 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.